Volume 24, Issue 1 pp. 71-80
Research Article

Design of novel ligands of CDP-methylerythritol kinase by mimicking direct protein-protein and solvent-mediated interactions

Victor Giménez-Oya

Victor Giménez-Oya

Department de Bioquímica i Biología Molecular, Universitat de Barcelona (UB), Avda Diagonal 645, E-08028 Barcelona, Spain

Search for more papers by this author
Óscar Villacañas

Óscar Villacañas

Department de Química Física, Universitat de Barcelona (UB) and the Institut de Recerca en Química Teòrica i Computacional (IQTCUB), Martí i Franquès 1, E-08028 Barcelona, Spain

Search for more papers by this author
Cristian Obiol-Pardo

Cristian Obiol-Pardo

Department de Química Física, Universitat de Barcelona (UB) and the Institut de Recerca en Química Teòrica i Computacional (IQTCUB), Martí i Franquès 1, E-08028 Barcelona, Spain

Search for more papers by this author
Meritxell Antolin-Llovera

Meritxell Antolin-Llovera

Department de Bioquímica i Biología Molecular, Universitat de Barcelona (UB), Avda Diagonal 645, E-08028 Barcelona, Spain

Search for more papers by this author
Jaime Rubio-Martinez

Jaime Rubio-Martinez

Department de Química Física, Universitat de Barcelona (UB) and the Institut de Recerca en Química Teòrica i Computacional (IQTCUB), Martí i Franquès 1, E-08028 Barcelona, Spain

Search for more papers by this author
Santiago Imperial

Corresponding Author

Santiago Imperial

Department de Bioquímica i Biología Molecular, Universitat de Barcelona (UB), Avda Diagonal 645, E-08028 Barcelona, Spain

Department de Bioquímica i Biología Molecular, Universitat de Barcelona (UB), Avda Diagonal 645, E-08028 Barcelona, Spain.Search for more papers by this author
First published: 30 December 2010
Citations: 6

Abstract

The methylerythritol 4-phosphate (MEP) pathway for the biosynthesis of the isoprenoid universal building blocks (isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP)) is present in most of human pathogens and is absent in animals, turning it into a promising therapeutic druggable pathway. Two different strategies, a pharmacophore-directed virtual screening and a protein-protein interaction (PPI)-mimicking cyclic peptide were used to search for compounds that bind to the PPI surface of the 4-(cytidine 5-diphospho)-2C-methyl-D-erythritol kinase (CMK), which catalyzes the fourth step of the MEP pathway. A significant part of the pharmacophore hypothesis used in this study was designed by mimicking water-mediated PPI relevant in the CMK homodimer complex stabilization. After database search and with the aid of docking and molecular dynamics (MD) simulations, a 7H-furo[3,2-g]chromen-7-one derivative and a cyclic peptide were chosen as candidates to be ligands of CMK. Their binding affinities were measured using surface plasmon resonance (SPR) technology. Copyright © 2010 John Wiley & Sons, Ltd.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.